SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Annual Wellness Visit, Subsequent — Jesse Owens — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJesse Owens
Date of birth1913-09-12
IdentifiersMRN HR-ML042-SYN-TD; SSN (made up) 000-42-8319
Document date1979-10-21
AuthorClarence Whitfield-Arroyo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Owens, now 66, returns for his subsequent annual wellness visit three weeks after his post-operative review; his last wellness visit was at his previous clinic a year ago. He is nine weeks past a thoracoscopic left upper lobectomy, after three cycles of chemoimmunotherapy, and has had no further cancer treatment since. He goes to pulmonary rehabilitation twice a week and walks 2.5 km most mornings. He has not smoked for four and a half months and takes varenicline 1 mg twice daily without side effects. He has gone back to speaking at two schools. He completed the health risk assessment beforehand and asked to talk about what he would want if the cancer came back. [S]

ElementDetail
VisitSubsequent annual wellness visit, age 66
Active conditionsLeft upper lobe adenocarcinoma, treated with chemoimmunotherapy and lobectomy (ypT1a N0, R0), now under surveillance; nicotine dependence in early remission on varenicline
MedicinesVarenicline 1 mg twice daily; no over-the-counter medicines or supplements
Safety eventsNo falls; no emergency visits since the operation
Functional statusIndependent in all activities and instrumental activities of daily living

Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Whitfield-Arroyo. [S]

DomainFinding
Self-rated healthGood, and getting better
PsychosocialLives with his wife; daughters call often; church and youth work; worries about the cancer returning, but sleeps well
TobaccoNo cigarettes for four and a half months, after 35 years at a pack a day; no vaping
Alcohol and drugsA beer or a glass of wine once or twice a week (AUDIT-C 2); no drugs
Physical activityWalks 2.5 km most mornings and attends pulmonary rehabilitation twice a week
NutritionEats regular meals; weight steady since the operation
Activities of daily livingIndependent in bathing, dressing, eating, toileting and transfers
Instrumental activities of daily livingDrives, manages his business, his medicines and his money
Home safetySmoke detectors working; no loose rugs; grab bar in the shower
Hearing and visionHears well; reading glasses; eye examination two years ago
Sun and heatWalks before the heat of the day and carries water

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; energy returning
EyesNegativeNo vision change
Ears, nose, mouth, and throatNegativeNo hoarseness or hearing loss
CardiovascularNegativeNo chest pain, palpitations or leg swelling
RespiratoryPositiveMild breathlessness on two flights of stairs, improving with rehabilitation; no cough or hemoptysis
GastrointestinalNegativeNo change in bowel habit or black stools
GenitourinaryNegativeNo urinary symptoms; no blood in the urine
MusculoskeletalPositiveOccasional aching along the left chest wall at the port sites; no bone pain
IntegumentaryNegativeNo rash; incisions healed
NeurologicalNegativeNo numbness, headaches or weakness
PsychiatricNegativeMood good; PHQ-2 0; no thoughts of self-harm
EndocrineNegativeNo heat or cold intolerance

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days (starting week), with a quit date on day 80.5 mg daily on days 1 to 3, then 0.5 mg twice daily on days 4 to 7Oral route1979-05-26 to 1979-06-01completedS
Varenicline 1 mg oral tablet, one tablet by mouth twice daily after food, for 12 weeks and then a further 12 weeks to prevent relapse1 mg twice daily after foodOral route1979-06-02activeS
Nivolumab 360 mg intravenous infusion over 30 minutes on day 1 of each 21-day cycle, for three cycles before surgery (one 240 mg and one 120 mg vial)Day 1 every 21 days for three cyclesIntravenous route1979-06-03 to 1979-07-15completedS
Carboplatin 10 mg/mL injection, 525 mg (AUC 5 by the Calvert formula, creatinine clearance 80 mL/min) intravenously on day 1 of each 21-day cycle, for three cyclesDay 1 every 21 days for three cyclesIntravenous route1979-06-03 to 1979-07-15completedS
Pemetrexed 500 mg/m2 (970 mg for a body surface area of 1.94 m2) intravenously over 10 minutes on day 1 of each 21-day cycle, for three cyclesDay 1 every 21 days for three cyclesIntravenous route1979-06-03 to 1979-07-15completedS
Folic acid 1 mg oral tablet, one tablet daily from one week before the first pemetrexed dose until three weeks after the lastOne tablet dailyOral route1979-05-26 to 1979-08-05completedS
Cyanocobalamin (vitamin B12) 1000 mcg intramuscular injection, one dose a week before the first pemetrexed dose (repeat every nine weeks while on pemetrexed)1000 mcg once; a second dose was not due before pemetrexed endedIntramuscular route1979-05-26 to 1979-05-26completedS
Dexamethasone 4 mg oral tablet, one tablet twice daily on the day before, the day of and the day after each pemetrexed dose4 mg twice daily for three days around each cycleOral route1979-06-02 to 1979-07-16completedS
Ondansetron 8 mg oral tablet, one tablet every 8 hours as needed for nausea during chemotherapy8 mg every 8 hours as neededOral route1979-06-03 to 1979-07-31completedS
Acetaminophen 500 mg oral tablet, two tablets every 8 hours as needed for pain after surgery1000 mg every 8 hours as neededOral route1979-08-22 to 1979-09-15completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1979-10-21Body height178cmS
1979-10-21Body weight75kgS
1979-10-21Body mass index (BMI) [Ratio]23.7kg/m2S
1979-10-21Systolic blood pressure124mm[Hg]S
1979-10-21Diastolic blood pressure76mm[Hg]S
1979-10-21Heart rate70/minS
1979-10-21Respiratory rate16/minS
1979-10-21Body temperature36.6CelS
1979-10-21Oxygen saturation in Arterial blood by Pulse oximetry96%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1979-10-21Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1979-10-21Total score [Mini-Cog]5{score}S
1979-10-21Total score [AUDIT-C]2{score}S

Physical Exam

Vital signs recorded on 1979-10-21; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell and upright; weight 75.0 kg, BMI 23.7; blood pressure 124/76, pulse 70
EyesNear vision 20/30 with reading glasses
EarsWhispered-voice test passed on both sides
NeckNo lymph nodes; thyroid not enlarged
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryBreath sounds slightly reduced at the left apex after the lobectomy; no crackles or wheeze; healed thoracoscopic incisions
MusculoskeletalTimed Up and Go 9 seconds; rises from a chair without using his arms
NeurologicalOriented; Mini-Cog 5 of 5; normal gait
SkinNo suspicious lesions
PsychiatricCalm, engaged and good-humored

Problems

ProblemClinical statusVerificationCodeProvenance
Solid, spiculated 2.9 cm nodule in the left upper lobe with an enlarged (1.6 cm) left hilar lymph node on today's low-dose screening CT, Lung-RADS 4X (very suspicious); no symptoms of lung cancer. PET-CT, tissue diagnosis and thoracic oncology review bookedresolvedconfirmed R91.1S — Synthetic presenting screening finding in a long-term smoker. Superseded by the diagnosis at the second visit.
Adenocarcinoma of the left upper lobe of the lung, cT1c N1 M0, stage IIB (AJCC 8th edition), resectable: 2.9 cm primary with a positive left interlobar (11L) node on EBUS; mediastinal nodes 4R, 4L and 7 negative; no metastases on PET-CT or brain MRI. PD-L1 tumor proportion score 40 percent (22C3); KRAS G12C mutation; no EGFR, ALK, ROS1, BRAF, MET exon 14, RET, NTRK or HER2 alterationactiveconfirmed C34.12S — Synthetic histology, stage and biomarkers linked to his documented adenocarcinoma of the left lung; in the modern episode it is found by screening while still resectable.
Nicotine dependence, cigarettes: a pack a day for 35 years (35 pack-years); smokes his first cigarette within 30 minutes of waking; two attempts to stop, each lasting a few weeks without medicineresolvedconfirmed F17.210S — Synthetic modern entry linked to his documented smoking; superseded at the visit after surgery by nicotine dependence in early remission.
Acute viral upper respiratory infection (rhinovirus on a respiratory panel) on day 13 of cycle 2 of chemoimmunotherapy: runny nose, sore throat and a dry cough for three days, no hypoxia, clear chest X-ray; immune-related pneumonitis and pneumonia excluded; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness; not a historical claim.
After thoracoscopic left upper lobectomy with mediastinal and hilar lymph node dissection: ypT1a N0 (0 of 16 nodes), R0, major pathologic response (6 percent residual viable tumor)activeconfirmed Z90.2S — Synthetic consequence of the synthetic operation.
Nicotine dependence, cigarettes, in early remission: no cigarettes since day 1 of cycle 1, about four months, on vareniclineactiveconfirmed F17.211S — Synthetic modern entry linked to his documented smoking.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Lung cancer screeningNot indicatedReplaced by surveillance CT after treatment for lung cancer; yearly low-dose CT resumes after the surveillance period
Tobacco cessationCompleted todayAbstinent four and a half months; varenicline and quitline support continue
Abdominal aortic aneurysm screeningUp to dateOne-time screening for men 65 to 75 who have smoked: the infrarenal aorta measured 2.1 cm on the staging CT, normal
Colorectal cancer screeningUp to dateNormal colonoscopy four years ago; next in six years
Prostate cancer screeningNot indicatedDiscussed; at 66, with a cancer under surveillance, he chose not to have a PSA test
Hepatitis C screeningUp to dateNegative before chemoimmunotherapy
Lipid panel and statin assessmentOrderedCoronary calcification on CT; fasting lipid panel and A1c ordered
Blood pressure screeningCompleted today124/76 mmHg
Depression screeningCompleted todayPHQ-2 score 0
Alcohol misuse screeningCompleted todayAUDIT-C score 2
Cognitive assessmentCompleted todayMini-Cog 5 of 5
Falls preventionCompleted todayTimed Up and Go 9 seconds; no falls
Influenza vaccineCompleted todayHigh-dose vaccine given
COVID-19 vaccineCompleted todayThis season's vaccine given
RSV vaccineCompleted todaySingle dose for an adult 60 to 74 at increased risk
Recombinant zoster vaccineCompleted todayDose 1 today; dose 2 in two to six months
Pneumococcal vaccineUp to datePCV20 before chemoimmunotherapy
Tetanus, diphtheria, and pertussisDueNo record of a booster in ten years; Tdap with the second zoster dose

Immunizations given today: Influenza vaccine, high-dose, this season; COVID-19 mRNA vaccine, this season's formula; Respiratory syncytial virus vaccine, single dose; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021;325(10):962-970 (PMID 33687470) (2021); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Lipid panel and A1c this week. Second zoster dose and Tdap in two to six months. Surveillance CT as booked. Next annual wellness visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 25 minutes, with his consent. He named a health care agent, recorded in the confidential part of the chart and not named here, and completed an Arizona health care power of attorney. He wants every treatment that offers a real chance of controlling the cancer if it comes back, including more surgery, radiation or medicines. If the cancer returned and could no longer be controlled, he would want his symptoms treated well and to stay at home, with his family and his church, rather than spend his last weeks in intensive care, and he would not want resuscitation in that situation. He wants his story told to young people so that they never start smoking. To be revisited at any change in his health and at least yearly. [S]